Siegfried’s Post

The Board of Directors of Siegfried Holding AG has appointed Marcel Imwinkelried as the new CEO with effect as of September 1, 2024. He will succeed Reto Suter, who has been leading the Siegfried Group as CEO ad interim since May 1, 2024, and will now focus again on his role as CFO. Read the media release: https://lnkd.in/dxUwtzcT

The Siegfried Acceleration Hub is here! As our hub for early-phase CDMO services, it will provide comprehensive support to customers in the pre-clinical and clinical development and manufacturing of Drug Substances. #growth #earlydevelopment #strongestteam

Siegfried has completed the acquisition of an early-phase CDMO site in Grafton, Wisconsin (US) from Curia Global, strengthening Siegfried’s customer offering for Drug Substances in terms of capabilities and geography. Read the media release: https://lnkd.in/dN6KKgEy #mediarelease #growth #earlydevelopment

The Intercompany Games held in Barcelona closed with record participation. More than 270 employees from our Siegfried Barberà and Siegfried El Masnou sites participated in these solidarity games that raised more than 24,000 Euros to support projects promoted by the Fundación Josep Carreras contra la Leucemia and the Associació 8000 estels, both focused on the fight against cancer in its different types, and the Asociación Norte Joven in its mission to promote social and labor integration of socially disadvantaged adolescents. The team spirit, healthy competition and, above all, the commitment of all Siegfried employees in such a noble cause made this event a real success once again. Congratulations to unit events for organizing these Intercompany Games and to the associations for the great work they are doing. #teamwork #givingback #strongestteam

Last week we welcomed the University of Applied Sciences Northwestern Switzerland (FHNW) and the Foundation Board at our headquarters to discuss the importance of cooperation between academic and industrial organizations as well as access to specialists and new technologies. Our Siegfried R&D team has had many fruitful collaborations with FHNW in the past, including many Bachelor theses, publications and participation in a patent application.

EGS Beteiligungen AG exercised its right to convert one of the convertible bonds issued in December 2020 with a coupon of 0.650% and a nominal value of CHF 40m into shares. Read the press release to learn more: https://lnkd.in/dJYHwrU9 #announcement #pressrelease #CDMO #bonds

Siegfried to acquire a CDMO specialized in early-phase development and manufacturing services in Grafton, Wisconsin (US). The new site is set to strengthen Siegfried's customer offering for Drug Substances in terms of capabilities and geography. Read more in the press release: https://lnkd.in/dzXDAVTq #announcement #pressrelease #growth #earlyphasedevelopment #CDMO

What is your company doing to meet the ever-increasing expectations of investors, shareholders and customers in relation to sustainability targets while complying with important political initiatives such as the European Green Deal? This was a key topic at the recent #DCAT Sustainability Summit roundtable where Luca Dalla Torre, Siegfried General Counsel and Chairman of the Sustainability Board, took part. Alongside industry experts, Annette Quincy-Garg, Nelleke Barning, and moderator Kelsey Achenbach, they discussed insights into metrics, common reporting standards and key requirements for assessing a company's environmental and sustainability performance. #bio #pharma #biopharma #pharmaceutical #sustainability #networking #event #dcat

Meet Patrick, who joined our Siegfried Hameln site after completing his studies. Throughout his time with Siegfried, he continues to learn and be challenged everyday. Want to learn more about Patrick's experience? Check out his full story https://lnkd.in/gYtVrFW8 #EmployeeAmbassador #Teamwork #ContinuousLearning #CareerGrowth #FinanceAndControlling